The clinical and ethical implications of hepatitis C for organ transplantation in Australia

Medical Journal of Australia

Volumn 165, Issue 5, 1996, Pages 282-285

  Kerridge, Ian H ^a,b   Saul, Peter ^b   Batey, Robert G ^b,c  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b JOHN HUNTER HOSPITAL   (Australia)

^c John Hunter Hospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY;

ABSENTEEISM; ADULT; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ARTICLE; CASE REPORT; HEALTH CARE POLICY; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; MALE; MEDICAL ETHICS; ORGAN DONOR; ORGAN TRANSPLANTATION;

EID: 0029798231     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1996.tb124967.x     Document Type: Article

References (49)

1. Australian Coordinating Committee on Organ Registries and Donation (Gladesville, Sydney, NSW). Newsletter, October 1995 (distributed to all intensive care and renal transplant units).
2. Shiener PA, Mor E, Schwartz ME, Miller CM. Use of hepatitis C-positive donors in liver transplantation. Transplant Proc 1993; 25: 3071.
3. Aswad S, Mendez R, Weingart RG, Mendez R. Expanding organ availability by using hepatitis C antibody-positive donors. Transplant Proc 1993; 25: 2270-2271.
4. Public Health Service inter-agency guidelines for screening donors of blood, plasma, organs, tissues and semen for evidence of hepatitis B and hepatitis C. MMWR Morb Mortal Wkly Rep 1991; 40: 1-17.
5. Milfred SK, Lake KD, Anderson DJ, et al Practices of cardiothoracic transplant centers regarding hepatitis C seropositive candidates and donors. Transplantation 1994; 57: 568-572.
6. Ramos EL, Kaiske BL, Alexander SR, et al. The evaluation of candidates for renal transplantation: the current practice of US transplant centers. Transplantation 1994; 57: 490-497.
7. Schweitzer EJ, Bartlett ST, Keay S, et al. Impact of hepatitis B or C infection on the practice of kidney transplantation in the United States. Transplant Proc 1993; 25: 1456-1457.
8. Tesi RJ, Waller K, Morgan CJ, et al. Transmission of hepatitits C by kidney transplantation - the risks Transplantation 1994; 57: 826-831.
9. Aeder MI, Shield CF, Tegtmeier GE, et al. The incidence and clinical impact of hepatitis C virus (HCV) positive donors in cadaveric transplantation. Transplant Proc 1993; 25: 1469-1471.
10. Diethelm AG, Roth D, Ferguson RM, et al. Transmission of HCV by organ transplantation. N Engl J Med 1992; 326: 410-411
11. Triolo G, Squiccimarro G, Baldi M, et al. Antibodies to hepatitis C virus in kidney transplantation. Nephron 1992; 61: 276-277.
12. Commonwealth Department of Human Services and Health. Hepatitis C. Commun Dis Intell 1994; 18: 533.
13. Archer GT, Buring ML, Clark B, et al. Prevalence of hepatitis C virus antibodies in Sydney blood donors. Med J Aust 1992; 157: 225-227.
14. McGuinness PH, Bishop GA, Lien A, et al. Detection of serum hepatitis C virus RNA in anti-HCV seropositive (RIBA positive) volunteer blood donors with normal ALT levels. Hepatology 1993; 18: 485-490.
15. Aeder MI, Shield CF, Tegtmeier GE, et al. Incidence and clinical impact of hepatitis C virus-positive donors in cadaveric transplantation. Transplant Proc 1993; 25: 1469-1471.
16. Pereira BJ, Wright RL, Schmid CH, et al. Screening and confirmatory testing of cadaveric organ donors for hepatitis C virus infection: a US National Collaborative Study. Kidney Int 1994; 46: 886-892.
17. Candinas D, Joller-Jemelka HI, Schlumpf R, et al. Hepatitis C RNA prevalence in a Western European organ donor pool and virus transmission by organ transplantation. J Med Microbiol 1994; 41: 220-223.
18. Talley NJ. Internal medicine. Sydney: Maclennan and Petty, 1990: 288.
19. Strasser SI, Desmond PV, Watson KJR, et al. The value of routine hepatitis C PCR in clinical practice. Gastroenterology 1994; 106: A991.
20. Bell J, Batey RG, Farrell GC, et al. Hepatitis C virus in intravenous drug users. Med J Aust 1990; 153: 274-276.
21. Strasser SI, Watson KJR, Lee CS, et al. Risk factors and predictors of outcome in an Australian cohort with hepatitis C infection. Med J Aust 1995; 162: 355-358.
22. Donahue JG, Munoz A, Ness PM, et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992; 327: 369-373.
23. Ikeda K, Saitoh S, Koida I, et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993; 18: 47-53.
24. David GI, Balart LA, Schiff ER, et al. Treatment of chronic hepatitis C with recombinant interferon alfa. A multicentre randomised controlled trial. N Engl:J Med 1989; 321: 1501-1506.
25. Ascher NL, Lake JR, Emond K, Roberts J. Liver transplantation for hepatitis C virus related cirrhosis. Hepatology 1994; 20: 245-275.
26. Roth D, Fernandez JA, Babischkin S, et al. Detection of hepatitis C virus infection among cadaver organ donors: evidence for low transmission disease. Ann Intern Med 1992; 117: 470-475.
27. Pereira BJ, Milford EL, Kirkman RL, Levey AS. Transmission of hepatitis C virus by organ transplantation. N Engl J Med 1991; 325: 454-460.
28. Wreghitt TG, Gray JJ, Allain JR et al. Transmission of hepatitis C virus by organ transplantation in the United Kingdom. J Hepatol 1994; 20: 768-772.
29. Maple PA, McKee T, Desselberger V, Wreghitt TG. Hepatitis C virus infections in transplant patients: serological and virological investigations. J Med Virol 1994; 44: 43-48.
30. McDonnell WM, Lucey MR. Hepatitis C virus transmission during organ transplantation. Hepatology 1993; 17: 162-164
31. Morales JM, Munoz MA, Castellano G, et al. Impact of hepatitis C in long-functioning renal transplants: a clinicopathological follow-up. Transplant Proc 1993; 25: 1450-1453.
32. Shuhart MC, Myerson D, Childs BH, et al. Marrow transplantation from hepatitis C virus seropositive donors: transmission rate and clinical course. Blood 1994; 84: 3229-3235.
33. Conrad EV, Gretch DR, Obermeyer KR, et al. Transmission of the hepatitis-C virus by tissue transplantation. J Bone Joint Surg Am 1995; 77: 214-224.
34. Zucker K, Cirocco R, Roth D, et al. Depletion of hepatitis C virus from procured kidneys using pulsatile perfusion preservation. Transplantation 1994; 57: 832-840.
35. Weir MR, Kirkman RL, Strom TB, Tilney NL. Liver disease in recipients of long-surviving renal allografts. Kidney Int 1985; 28: 839-844.
36. Chazouilleres O, Kim M, Combs C, et al. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology 1994; 106: 994.
37. Pereira BJG, Milford RL, Kirkman RL, et al. Liver disease and HCV infection after transplantation of organs from hepatitis C antibody-positive donors. Transplant Proc 1993; 25: 1458-1459.
38. Huang CC, Lai MK, Lin MW, et al. Transmission of hepatitis C virus by renal transplantation. Transplant Proc 1993; 25: 1474-1475.
39. Roth D, Zucker K, Cirocco R, et al. The impact of hepatitis C virus infection on renal allograft recipients. Kidney Int 1994; 45: 238-244.
40. Fritsche C, Brandes JC, Delaney SR, et al. Hepatitis C is a poor prognostic indicator in black kidney transplant recipients. Transplantation 1993; 55: 1283-1287.
41. Ynares C, Johnson HK, Kerlin T, et al. Impact of pretransplant hepatitis C antibody status upon long-term patient and renal allograft survival - a 5 and 10-year follow-up. Transplant Proc 1993; 25: 1466-1468.
42. Kînig V, Bauditz J, Neuhaus P, et al. Follow-up of hepatitis C virus (HCV) reinfection in liver allograft recipients. J Hepatol 1991; 13: 540.
43. Wright TL, Ferell L, Donegan E, et al. Impact of hepatitis C viral (HCV) infection on the allograft following liver transplantation. J Hepatol 1991; 14: 51A.
44. Morales JM, Andres A, Campistol JM. Hepatitis C virus and organ transplantation. N Engl J Med 1993; 328: 511-513.
45. Preston FE, Jarvis LM, Markis M, et al. Heterogeneity of hepatitis C virus genotypes in haemophilia: relationship with chronic liver disease. Blood 1995; 85: 1259-1262.
46. Farci P, Alter HJ, Govindarajan S, et al. Lack of protective immunity against reinfection with hepatitis C virus. Science 1992; 258: 135-140.
47. King P. Renal transplantation. N Engl J Med 1994; 331: 1719.
48. Féray C, Gigou M, Samuel D, et al. Direct evidence for a more pathogenic effect of HCV type II: the model of liver transplantation. J Hepatol 1993; 28 Suppl 1: 54.
49. Shorrock C, Neuberger J. The changing face of liver transplantation. Gut 1993; 34: 295-298.